Compounds > phosphatidylcholines
Page last updated: 2024-09-05

phosphatidylcholines and Carcinoma, Small Cell

phosphatidylcholines has been researched along with Carcinoma, Small Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jain, S; Khandhuja, KL; Tiwary, AK; Utreja, P; Yadav, S1
Benazzouz, F; Cordobes, MD; de Beco, V; Moretti, JL; Starzec, A1

Other Studies

2 other study(ies) available for phosphatidylcholines and Carcinoma, Small Cell

ArticleYear
Efficacy and toxicological studies of cremophor EL free alternative paclitaxel formulation.
    Current drug safety, 2011, Nov-01, Volume: 6, Issue:5

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Cell Line, Tumor; Deoxycholic Acid; Dose-Response Relationship, Drug; Excipients; Female; Glycerol; Glycine max; Humans; Lethal Dose 50; Liposomes; Lung Neoplasms; Male; Maximum Tolerated Dose; Mice; Paclitaxel; Phosphatidylcholines

2011
Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines.
    Nuclear medicine communications, 1999, Volume: 20, Issue:5

    Topics: Adenocarcinoma; Biological Transport; Breast Neoplasms; Carcinoma, Small Cell; Cholesterol; Drug Resistance, Multiple; Female; Humans; Kinetics; Liposomes; Lung Neoplasms; Mouth Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured

1999